Exelixis (EXEL) Interest Expenses (2010 - 2018)
Exelixis (EXEL) recorded quarterly Interest Expenses of -$1000.0 in Q4 2018, down 200.0% quarter-over-quarter from $1000.0 in Q3 2018.
Exelixis (EXEL) Interest Expenses (2010 - 2018) Analysis & Trends
Exelixis' Interest Expenses history runs 9 years deep, the most recent figure standing at -$1000.0 for Q4 2018.
- In Q4 2018, Interest Expenses changed N/A year-over-year to -$1000.0; the TTM figure through Sep 2019 stood at -$1000.0 (down 200.0% YoY), while the FY2017 annual figure was $8.7 million, down 73.75% from the prior year.
- Interest Expenses was -$1000.0 for Q4 2018 at Exelixis, down from $1000.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $12.4 million in Q1 2015 to a low of -$1000.0 in Q4 2018.
- Historically, Interest Expenses has averaged $7.7 million across 5 years, with a median of $10.0 million in 2015.
- The sharpest annual moves came in 2014 and 2017: Interest Expenses rose 7.49% in 2014, then plunged 59.25% in 2017.
- A 5-year view of Interest Expenses shows it stood at $5.2 million in 2014, then jumped by 91.66% to $10.0 million in 2015, then sank by 74.5% to $2.6 million in 2016, then jumped by 66.43% to $4.3 million in 2017, then slumped by 100.02% to -$1000.0 in 2018.
- The last three Interest Expenses figures came in at -$1000.0 (Q4 2018), $1000.0 (Q3 2018), and $4.3 million (Q2 2017), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 61,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -332,000.00 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -5.58 Mn |
| 10 | Exelixis | 13.37 Bn | 12.59 Bn | 590.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 28, 2018 | -1,000.00 |
| Dec 28, 2018 | -1,000.00 |
| Sep 28, 2018 | 1,000.00 |
| Sep 28, 2018 | 1,000.00 |
| Jun 30, 2017 | 4.26 Mn |
| Jun 30, 2017 | 4.26 Mn |
| Mar 31, 2017 | 4.42 Mn |
| Mar 31, 2017 | 4.42 Mn |
| Dec 30, 2016 | 2.56 Mn |
| Dec 30, 2016 | 2.56 Mn |
| Sep 30, 2016 | 7.83 Mn |
| Sep 30, 2016 | 7.83 Mn |
| Jun 30, 2016 | 10.45 Mn |
| Jun 30, 2016 | 10.45 Mn |
| Mar 31, 2016 | 10.29 Mn |
| Mar 31, 2016 | 10.29 Mn |
| Sep 30, 2015 | 10.04 Mn |
| Sep 30, 2015 | 10.04 Mn |
| Jun 30, 2015 | 11.96 Mn |
| Jun 30, 2015 | 11.96 Mn |